Amtan Medical Centres are now taking appointments for Phase 1b COVID-19 Vaccinations
Amtan Medical Centres are now taking appointments for Phase 1b COVID-19 Vaccinations
COVID-19 Vaccines are here. Find out what this means for you and how Amtan can help.
This page is to help guide you to the COVID-19 Vaccine, as approved by the Government of Australia, following the schedule. Find out below if you are eligible for the vaccine and how to receive it.
Read below to find out the eligibility criteria for receiving the vaccine. COVID-19 vaccines are being rolled out to people in phases, with those most at risk receiving their vaccinations first.
You can then make a booking to receive your vaccine.
Having a safe and effective COVID-19 vaccine is one way we can protect our community against coronavirus.
COVID-19 vaccines help to prevent serious illness and death from COVID-19, and they are free for everyone in Australia.
Amtan Medical Centres are pleased to advise that we are an approved vaccination provider for COVID-19 vaccines. We are happy to help provide COVID-19 immunisation for our patients and the wider community.
Dr Tanya Unni, Amtan Medical Director, recently spoke with Associate Professor Carl de Wet, Primary Care Lead for the COVID-19 pandemic response, part of the team responsible for getting COVID Vaccines distributed to the Queensland population.
Watch the full replay to understand more about the vaccine from the trusted authority.
The Vaccine rollout will happen in 5 stages. Below is the COVID-19 vaccine national
As of 22 March 2021, Phase 1b will be commencing. The COVID vaccination is being rolled out to people in phases with those most at risk. The below groups have been identified for Phase 1b:
You can also check which rollout phase you will be in for your COVID- 19 vaccine by using the COVID-19 Vaccine Eligibility Checker here: https://covid-vaccine.healthdirect.gov.au/eligibility
The following healthcare workers are eligible in Phase 1b:
The following carers and workers are eligible in Phase 1b:
The following Critical and High Risk Workers are eligible in Phase 1b:
The following Licensed meat processing workers are eligible in Phase 1b:
The following Elderly peoples are eligible in Phase 1b:
The following Aboriginal and Torres Strait Islander People are eligible in Phase 1b:
The following people with Underlying medical conditions are eligible in Phase 1b:
COVID-19 vaccinations are voluntary and will be bulk-billed.
You will need to arrive at least 10 minutes before your scheduled appointment time to complete any relevant paperwork, if not done online.
When it is your turn to get vaccinated, you can call us on 1300-4-AMTAN (1300-4-26826) or book your appointment online.
You will need to book your appointments to get your first and second doses of the vaccine 12 weeks apart.
You can also book online. Make sure you book an appointment for your first and second doses. Please give us a call before your vaccination appointment, you should make sure your details are up to date with Medicare.
Please do not come to your vaccination appointment:
To keep you and our community safe, before and after vaccination, it is important that you continue to:
Some people may experience mild side effects after getting the COVID-19 X vaccine. Mild side effects of mild and don’t last for long. If you have a side effect that worries you please call the clinic and book an appointment with your doctor. Most side effects are mild and don’t last for long.
Common reactions to COVID-19 vaccinations include:
The vaccine will be adminstered in 2 doses, staged 12 weeks apart. At the time of your first consulation, you will be booked in for your second appointment.
After your COVID-19 vaccination, it is important that you continue to protect those around you by:
• Washing your hands regularly with soap and water
• Keeping 1.5m from others
• Making sure the COVIDSafe app is active on your phone
• Staying informed about local restrictions.
COVID-19 Vaccine AstraZeneca is a vaccine that can prevent people from becoming ill from COVID-19. COVID-19 Vaccine AstraZeneca does not contain any live SARS-CoV-2 virus, and it cannot give you COVID-19. It contains the genetic code for an important part of the SARS-CoV-2 virus called the spike protein. The spike protein has been inserted into a harmless common cold ‘carrier’ virus (an adenovirus). The adenovirus carrier brings the spike protein into your cells so that they can read it and make copies of the spike protein. Your immune system will then learn to recognise and fight against the SARS-CoV-2 virus. The adenovirus has been modified so that it cannot replicate once it is inside cells. This means it cannot spread to other cells and cause infection.
To prevent COVID-19, everyone aged 16 years and older should get vaccinated. The COVID-19 Vaccine AstraZeneca is suitable for people aged 18 years and older, with a few exceptions specified in this information sheet. People aged 16 and 17 years can receive a different vaccine (Comirnaty, the Pfizer COVID-19 vaccine). Vaccination is voluntary.
People aged 18 years and older can receive this COVID-19 Vaccine AstraZeneca.
Certain groups of people are prioritised to receive vaccines first because they are at higher risk of exposure to the COVID-19 virus (e.g. workers in border or quarantine facilities, a healthcare facility or aged-care facility) or severe illness and death from COVID-19 (e.g. are older or have underlying medical conditions), or if they work in services critical to societal functioning.
You should not receive this vaccine if you have had:
anaphylaxis (a type of severe allergic reaction) to a previous dose of the same
COVID-19 vaccine, or anaphylaxis after exposure to any component of a COVID-19 vaccine.
A combination of several clinical trials showed that COVID-19 Vaccine AstraZeneca is effective in preventing COVID-19 in people aged 18 years and older. People who had two doses of COVID-19 Vaccine AstraZeneca were about 62-70 per cent less likely to get COVID-19 than people who did not get the vaccine. Because of the small number of people
aged 65 years or older included in the trial, we are not as sure if the vaccine is equally effective in people over the age of 65 years compared with younger adults. However, none of these older people who received the vaccines got severe COVID-19 disease or required hospital treatment. Early experience in Scotland showed that COVID-19 vaccination was
effective in preventing older people requiring hospital treatment for COVID-19, and most of them received COVID-19 Vaccine AstraZeneca. More data on the effectiveness of this vaccine in older adults is expected to be available soon.
Protection against COVID-19 starts from about 3 weeks after the first dose of COVID-19 Vaccine AstraZeneca. While one dose may give some protection, it may only last for the short-term up to about 12 weeks. The second dose boosts antibody levels and is likely to prolong the duration of protection. In the clinical trial described above, the vaccine appeared to be more effective when people had a longer interval between the 2 doses. This is why it is better to receive 2 doses about 12 weeks apart. No vaccine is 100 per cent effective, so it is possible that you can still get sick from COVID-19 after vaccination.
We do not know how long the protection from COVID-19 Vaccine AstraZeneca will last after completing the two doses. We will learn more about this over time.
We currently do not know how effective COVID-19 vaccines are at preventing spread of the virus. This means that SARS-CoV-2 could potentially still infect a vaccinated person. Even if they have no symptoms or only mild symptoms they could still pass it on to others.
This is why it is important to continue other preventative measures like:
COVID-19 testing and quarantine/isolation as required by your state/territory.
If you have been vaccinated with two doses of COVID-19 Vaccine AstraZeneca, you should still get a COVID-19 test if you have symptoms that meet testing criteria according to your local health authority (e.g. fever, cough, sore throat).
People with certain conditions may need additional precautions such as staying for 30 minutes of observation after having their vaccine or consulting an allergy specialist. Tell your immunisation provider if you have had:
An allergic reaction to a previous dose of a COVID-19 vaccine or to an ingredient of the vaccine
anaphylaxis to other vaccines or to other medicines. Your provider can check to ensure there are no common ingredients with the COVID-19 vaccine you are receiving
a mast cell disorder.
If you have a bleeding disorder or you are taking a blood-thinning medication (anticoagulant), tell your immunisation provider. Your immunisation provider can help determine whether it is safe for you to have an intramuscular injection, and help to decide the best timing for injection.
People with immunocompromise includes those who have a medical condition that weakens their immune system. It also includes those who may be taking medications that suppress their immune system.
The Australian Government strongly recommends people with immunocompromise receive COVID-19 vaccination. COVID-19 Vaccine AstraZeneca does not behave like a ‘live vaccine’. The adenovirus carrier has been modified so that it cannot replicate or spread to other cells, and it cannot cause infection. It is safe in people with immunocompromise.
People with immunocompromise, including those living with HIV, have a higher risk of severe illness from COVID-19, including a higher risk of death.
Clinical trials for COVID-19 Vaccine AstraZeneca did not include people with immunocompromise. A clinical trial is being conducted of COVID-19 Vaccine AstraZeneca given to people with stable HIV infection, with results expected in a few months. We do not know if COVID-19 Vaccine AstraZeneca is as effective in people with immunocompromise compared to the rest of the population. It is possible that COVID-19 Vaccine AstraZeneca might not be as effective in people with immunocompromise as it is in the general population. It is important to continue other preventative measures such as physical distancing after vaccination.
If you are breastfeeding, you can have COVID-19 Vaccine AstraZeneca. You do not need to stop breastfeeding after vaccination.
Pregnant women are not routinely recommended to have COVID-19 Vaccine AstraZeneca, but can consider vaccination:
If they are at higher risk of getting COVID-19, for example due to their occupation, or
If they have risk factors for severe illness, for example due to pre-existing medical conditions.
If you are pregnant, your healthcare provider can help you to assess the benefits and risks of vaccination.
If you have ever had COVID-19 in the past, tell your immunisation provider. Your provider may advise to wait for up to six months after recovery before having a COVID-19 vaccine. If you have ongoing illness from COVID-19, discuss the best timing of vaccination with your treating doctor.
For more information on TGA’s COVID-19 vaccine approval process visit: www.tga.gov.au/covid-19-vaccine-approval-process
For the latest COVID-19 vaccine updates visit: www.health.gov.au/covid19-vaccines
For the latest official coronavirus news, updates and advice from the Australian Government visit: www.australia.gov.au
Yes, this vaccination is bulk billed.
Australians can already access their immunisation history statement through Medicare for proof of vaccination, both digitally and in hard copy, if required.
Statements can be viewed on an individual’s Medicare online account or via the Medicare app.
Your immunisation history statement will record your COVID-19 vaccinations, following each dose.
Click below to book your Vaccination appointment at the Amtan Medical Centre nearest to you.